Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis

ClinicalTrials.gov ID: NCT02970968

Public ClinicalTrials.gov record NCT02970968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo.

Study identification

NCT ID
NCT02970968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
152 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2016 (Actual)
Primary completion
Nov 2018 (Actual)
Completion
Dec 2018 (Actual)
Last update posted
Aug 6, 2024

2016 – 2018

United States locations

U.S. sites
38
U.S. states
24
U.S. cities
37
Facility City State ZIP Site status
Vanda Investigational Site Dothan Alabama 36305 —
Vanda Investigational Site Huntsville Alabama 35801 —
Vanda Investigational Site Tucson Arizona 85712 —
Vanda Investigational Site Little Rock Arkansas 72211 —
Vanda Investigational Site Chula Vista California 91910 —
Vanda Investigational Site Los Angeles California 90095 —
Vanda Investigational Site Palo Alto California 94305 —
Vanda Investigational Site San Francisco California 94115 —
Vanda Investigational Site Jacksonville Florida 32256 —
Vanda Investigational Site Largo Florida 33777 —
Vanda Investigational Site Miami Florida 33134 —
Vanda Investigational Site Athens Georgia 30607 —
Vanda Investigational Site Elgin Illinois 60123 —
Vanda Investigational Site Indianapolis Indiana 46202 —
Vanda Investigational Site Louisville Kentucky 40202 —
Vanda Investigational Site Marrero Louisiana 70072 —
Vanda Investigational Site Chevy Chase Maryland 20815 —
Vanda Investigational Site Boston Massachusetts 02114 —
Vanda Investigational Site Boston Massachusetts 02215 —
Vanda Investigational Site Wyoming Michigan 49519 —
Vanda Investigational Site Minneapolis Minnesota 55114 —
Vanda Investigational Site Pascagoula Mississippi 39564 —
Vanda Investigational Site St Louis Missouri 63104 —
Vanda Investigational Site Great Neck New York 11023 —
Vanda Investigational Site New York New York 10028 —
Vanda Investigational Site Raleigh North Carolina 27612 —
Vanda Investigational Site Salisbury North Carolina 28144 —
Vanda Investigational Site Huber Heights Ohio 45424 —
Vanda Investigational Site Mentor Ohio 44060 —
Vanda Investigational Site Tulsa Oklahoma 74104 —
Vanda Investigational Site Philadelphia Pennsylvania 19140 —
Vanda Investigational Site Chattanooga Tennessee 37421 —
Vanda Investigational Site Jackson Tennessee 38305 —
Vanda Investigational Site Nashville Tennessee 37211 —
Vanda Investigational Site El Paso Texas 79905 —
Vanda Investigational Site Houston Texas 77030 —
Vanda Investigational Site Richardson Texas 75082 —
Vanda Investigational Site Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02970968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2024 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02970968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →